Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:54:24.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    - The study page now shows a 403 Forbidden error page, replacing the study record content. This change prevents viewing the trial details and related information, reflecting a blockage in accessing essential information on the page.
    Difference
    18%
    Check dated 2026-09-22T23:00:29.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.6 to v3.7.0, indicating a version change of the page components.
    Difference
    0.0%
    Check dated 2026-09-15T21:47:57.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    New page metadata items were added: Rheumatoid arthritis, related topics, MedlinePlus Genetics, and an updated revision tag Revision: v3.6.6; the previous tag Revision: v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-09-01T18:34:11.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    An annotation was added to the 'Other Study ID Numbers' section clarifying that the 2015 identifier corresponds to a U.S. NIH grant/contract.
    Difference
    0.0%
    Check dated 2026-08-25T23:24:13.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The related topics section no longer includes 'Rheumatoid arthritis' and 'MedlinePlus Genetics'. This change affects how the study is indexed and described in relation to the condition and genetics resources.
    Difference
    0.1%
    Check dated 2026-08-18T22:10:20.000Z thumbnail image

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.